Sarepta appoints Michael Severino as CEO to steer company beyond a turbulent year
read at Endpoints ↗Neutral
Sarepta Therapeutics announced that Michael Severino will become its chief executive officer, taking over from longtime leader Doug Ingram.
Severino is slated to start on Tuesday and joins the company from Flagship, where he was involved in gene‑editing initiatives.
The leadership shift follows a challenging year for Sarepta, and the board hopes the new CEO will help stabilize and refocus the business.
source
This writeup was produced by pharmadog from original reporting by Endpoints.
Original headline: “Sarepta turns to Michael Severino as CEO, looking to move past recent turmoil”
read at Endpoints ↗90 words · retrieved Jul 27
comments(0)
5-min edit window · permanent after that